Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical
Corp., and Alere Inc.
LONDON, August 16, 2013
LONDON, August 16, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market ended on a lower note on Thursday, August 15, 2013. The
Dow Jones Industrial Average closed at 15,112.19, down 1.47%, the S&P 500
closed at 1,661.32, down 1.43%, and the NASDAQ composite finished at 3,606.12,
down 1.72%. Shares in the healthcare sector companies also fell, tracking
losses in the broader market. The major movers in the sector included Vertex
Pharmaceuticals Inc. (NASDAQ: VRTX), Orexigen Therapeutics Inc. (NASDAQ:
OREX), MAKO Surgical Corporation (NASDAQ: MAKO), and Alere Inc. (NYSE: ALR).
AAAResearchReports.com free coverage on VRTX, OREX, MAKO, and ALR is available
upon registration at:
Shares in Vertex Pharmaceuticals Inc. fell sharply on Thursday, tracking
losses in the broader market. The company's shares ended the day 1.65% lower
at $76.96 after vacillating between $76.60 and $78.26. A total of 1.44 million
shares were traded which is below the daily average volume of 1.62 million.
Vertex Pharmaceuticals Inc.'s shares have lost 0.67% in the last three trading
sessions, compared to a decline of 1.67% in the S&P 500. Despite the recent
losses, the company's shares are trading above their 200-day moving average.
Download free technical research on VRTX by signing up at:
On Thursday, shares in Orexigen Therapeutics Inc. plunged 4.02%. The company's
shares traded between $6.90 and $7.19 before ending the day at $6.93. A total
of 1.04 million shares were traded which is below the daily average volume of
1.26 million. Orexigen Therapeutics Inc.'s shares have tumbled 4.81% in the
last three trading sessions. Despite the recent losses, the company's shares
have gained 9.31% in the last one month, and 12.14% in the last three months,
outperforming the S&P 500. Register now and get access to free analysis on
Shares in MAKO Surgical Corporation declined on Thursday, extending their
recent losses. The company's shares closed the day at $14.15, down 3.08%,
after oscillating between $14.10 and $14.49. A total of 0.58 million shares
were traded which is below the daily average volume of 0.90 million. The stock
has gained 28.52% in the last three months, outperforming the S&P 500 which
has gained 0.15% during the same period. Furthermore, the stock is trading
above its 50-day and 200-day moving averages. Sign up and read our
complimentary report on MAKO at:
Alere Inc.'s shares finished the day 2.93% lower on Thursday after rising
sharply in the previous trading session. The company's shares vacillated
between $31.40 and $32.48 before closing the day at $31.75. A total of 0.63
million shares were traded which is marginally above the daily average volume
of 0.61 million. Alere Inc.'s shares have lost 0.84% in the last three trading
sessions, outperforming the S&P 500 which has lost 1.67% during the same
period. Despite the recent losses, the company's shares have surged 16.69% in
the last one month and 19.63% in the last three months, outperforming the S&P
500. The free report on ALR can be downloaded by signing up now at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by a CFA ® charterholder. However, we are only human
and are prone to make mistakes. If you notice any errors or omissions,
please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
SOURCE AAA Research Reports
Press spacebar to pause and continue. Press esc to stop.